SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 14 filers reported holding SUMMIT THERAPEUTICS PLC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $146,000 | -31.8% | 49,257 | -45.4% | 0.00% | 0.0% |
| Q1 2020 | $214,000 | +2.9% | 90,273 | -30.7% | 0.00% | 0.0% |
| Q4 2019 | $208,000 | -32.9% | 130,312 | -24.8% | 0.00% | 0.0% |
| Q3 2019 | $310,000 | +40.9% | 173,385 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $220,000 | -31.5% | 173,385 | -1.2% | 0.00% | 0.0% |
| Q1 2019 | $321,000 | +52.9% | 175,500 | -4.2% | 0.00% | 0.0% |
| Q4 2018 | $210,000 | -45.3% | 183,160 | +5.9% | 0.00% | -50.0% |
| Q3 2018 | $384,000 | +47.1% | 172,952 | +62.4% | 0.00% | +100.0% |
| Q2 2018 | $261,000 | -85.2% | 106,505 | -22.2% | 0.00% | -87.5% |
| Q1 2018 | $1,767,000 | +10.8% | 136,922 | -5.0% | 0.01% | +14.3% |
| Q4 2017 | $1,595,000 | +158.1% | 144,083 | +192.8% | 0.01% | +133.3% |
| Q3 2017 | $618,000 | +326.2% | 49,207 | +282.9% | 0.00% | +200.0% |
| Q2 2017 | $145,000 | -15.2% | 12,851 | +0.0% | 0.00% | 0.0% |
| Q1 2017 | $171,000 | – | 12,850 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Asset Management, LLC | 10,956 | $20,488 | 0.02% |
| Lindbrook Capital, LLC | 782 | $1,462 | 0.00% |